Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,449 | 395 | 96.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208.12 | 5 | 1.8% |
| Education | $203.43 | 3 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,819 | 80 | $0 (2024) |
| Lilly USA, LLC | $1,702 | 53 | $0 (2024) |
| Amgen Inc. | $827.81 | 27 | $0 (2024) |
| Celgene Corporation | $752.89 | 13 | $0 (2019) |
| Janssen Biotech, Inc. | $747.06 | 25 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $553.47 | 22 | $0 (2024) |
| LEO Pharma Inc. | $549.39 | 23 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $472.83 | 17 | $0 (2024) |
| GENZYME CORPORATION | $422.60 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $378.13 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,812 | 73 | Janssen Biotech, Inc. ($402.51) |
| 2023 | $1,867 | 73 | AbbVie Inc. ($826.60) |
| 2022 | $1,872 | 70 | ABBVIE INC. ($289.79) |
| 2021 | $1,127 | 42 | Lilly USA, LLC ($235.20) |
| 2020 | $931.56 | 31 | AbbVie Inc. ($278.99) |
| 2019 | $1,886 | 58 | AbbVie, Inc. ($479.65) |
| 2018 | $1,199 | 41 | AbbVie, Inc. ($294.59) |
| 2017 | $1,165 | 15 | Lilly USA, LLC ($435.73) |
All Payment Transactions
403 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $70.76 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Immunology | ||||||
| 10/29/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), JUBLIA | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: DERMATOLOGY | ||||||
| 10/09/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $25.55 | General |
| 10/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Immunology | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.76 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Dermatology | ||||||
| 09/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $39.40 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: Immunology | ||||||
| 08/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Immunology | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: Immunology | ||||||
| 08/14/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Inflammation & Immunology | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $37.01 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 9,347 | 18,209 | $4.0M | $858,096 |
| 2022 | 25 | 9,433 | 18,674 | $4.2M | $901,833 |
| 2021 | 25 | 8,629 | 15,864 | $3.5M | $767,482 |
| 2020 | 23 | 8,395 | 15,582 | $2.4M | $717,662 |
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 6,225 | 12,305 | $2.9M | $629,684 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 483 | 681 | $202,257 | $40,836 | 20.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 301 | 400 | $135,200 | $27,846 | 20.6% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 230 | 295 | $105,170 | $23,839 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 161 | 191 | $80,220 | $16,774 | 20.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 168 | 192 | $72,576 | $16,624 | 22.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 319 | 458 | $102,134 | $16,445 | 16.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 362 | 397 | $55,561 | $12,123 | 21.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 69 | 91 | $51,142 | $11,659 | 22.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 261 | 2,042 | $46,966 | $10,754 | 22.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 127 | 232 | $38,976 | $9,536 | 24.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 270 | 353 | $39,536 | $9,350 | 23.6% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 122 | 307 | $27,937 | $6,653 | 23.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 18 | 21 | $21,231 | $5,251 | 24.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 31 | $18,414 | $4,177 | 22.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 57 | 57 | $21,033 | $3,898 | 18.5% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 16 | 18 | $12,294 | $2,732 | 22.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 21 | $17,073 | $2,109 | 12.4% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 15 | 15 | $9,405 | $1,968 | 20.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $10,940 | $1,942 | 17.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 36 | 41 | $7,626 | $1,678 | 22.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 19 | 20 | $4,956 | $1,118 | 22.6% |
| 69100 | Biopsy of ear | Office | 2023 | 20 | 21 | $6,741 | $1,102 | 16.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 5,991 | 11,819 | $2.7M | $609,718 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 595 | 871 | $256,945 | $52,490 | 20.4% |
About Dr. John Wofford, MD
Dr. John Wofford, MD is a Dermatopathology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2012. The National Provider Identifier (NPI) number assigned to this provider is 1245596451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Wofford, MD has received a total of $11,860 in payments from pharmaceutical and medical device companies, with $1,812 received in 2024. These payments were reported across 403 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($11,449).
As a Medicare-enrolled provider, Wofford has provided services to 35,804 Medicare beneficiaries, totaling 68,329 services with total Medicare billing of $3.2M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Practice Information
- Specialty Dermatopathology
- Other Specialties Dermatology
- Location Dallas, TX
- Active Since 04/02/2012
- Last Updated 10/06/2023
- Taxonomy Code 207ND0900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245596451
Products in Payments
- Otezla (Drug) $1,499
- TALTZ (Drug) $1,040
- SKYRIZI (Biological) $1,011
- RINVOQ (Biological) $688.49
- TREMFYA (Drug) $577.83
- DUPIXENT (Biological) $495.37
- Humira (Biological) $478.00
- Sotyktu (Drug) $236.02
- ADBRY (Biological) $233.38
- Impoyz (Drug) $214.91
- ENSTILAR (Drug) $209.24
- LIBTAYO (Biological) $181.60
- Seysara (Drug) $179.65
- ILUMYA (Biological) $176.25
- DUPIXENT (Drug) $173.78
- EUCRISA (Drug) $170.54
- REMICADE (Biological) $169.23
- Winlevi (Drug) $152.75
- OPZELURA (Drug) $143.63
- BOTOX COSMETIC (Biological) $130.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatopathology Doctors in Dallas
Dr. Clay Cockerell, Md, MD
Dermatopathology — Payments: $38,464
Titilola Sode
Dermatopathology — Payments: $8,958
Dr. Mara Dacso, M.d, M.D
Dermatopathology — Payments: $6,401
Gregory Hosler, M.d., P.h.d, M.D., P.H.D
Dermatopathology — Payments: $4,025
Dr. Yevgeniya Rainwater, M.d, M.D
Dermatopathology — Payments: $705.88
Dr. Joseph Susa, Do, DO
Dermatopathology — Payments: $553.43